[HTML][HTML] Future perspective of chemotherapy and pharmacotherapy in thymic carcinoma
R Kitadai, Y Okuma - Cancers, 2021 - mdpi.com
Simple Summary Thymic carcinoma is a rare cancer, and its biology remains largely
unknown. Although complete surgical resection is a standard treatment for thymic …
unknown. Although complete surgical resection is a standard treatment for thymic …
[PDF][PDF] Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma. Cancers 2021, 13, 5239
R Kitadai, Y Okuma - 2021 - pdfs.semanticscholar.org
Thymic carcinoma is a rare cancer that arises from thymic epithelial cells. Its nature and
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma.
R Kitadai, Y Okuma - Cancers, 2021 - europepmc.org
Thymic carcinoma is a rare cancer that arises from thymic epithelial cells. Its nature and
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma.
R Kitadai, Y Okuma - Cancers, 2021 - search.ebscohost.com
Abstract Simple Summary: Thymic carcinoma is a rare cancer, and its biology remains
largely unknown. Although complete surgical resection is a standard treatment for thymic …
largely unknown. Although complete surgical resection is a standard treatment for thymic …
Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma
R Kitadai, Y Okuma - Cancers, 2021 - pubmed.ncbi.nlm.nih.gov
Thymic carcinoma is a rare cancer that arises from thymic epithelial cells. Its nature and
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
[HTML][HTML] Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma
R Kitadai, Y Okuma - Cancers, 2021 - ncbi.nlm.nih.gov
Thymic carcinoma is a rare cancer that arises from thymic epithelial cells. Its nature and
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma
R Kitadai, Y Okuma - Cancers, 2021 - search.proquest.com
Thymic carcinoma is a rare cancer that arises from thymic epithelial cells. Its nature and
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
Future Perspective of Chemotherapy and Pharmacotherapy in Thymic Carcinoma.
R Kitadai, Y Okuma - Cancers, 2021 - europepmc.org
Thymic carcinoma is a rare cancer that arises from thymic epithelial cells. Its nature and
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …
pathology differ from that of benign thymoma, presenting a poorer prognosis. If surgically …